【恒瑞医药副董事长戴洪斌：登陆港股是公司加速创新国际化的关键一步】金十数据5月23日讯，恒瑞医药在香港联合交易所主板正式挂牌上市，迈入“A+H”双平台时代。恒瑞医药副董事长戴洪斌表示，登陆港股，是恒瑞医药迈向国际资本市场、加速创新国际化的关键一步，也是公司发展的又一重要里程碑。公司将以此次上市为新起点，努力研发更多具有国际先进水平的创新药。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.